Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive
-
July 13, 2017
Lindsell named to key VICTR, IMPH and Biostatistics leadership roles
Christopher Lindsell, Ph.D., nationally known for building clinical, translational and emergency medicine research programs at the University of Cincinnati, has been named director of the Research Methods Program in the Vanderbilt Institute of Clinical and Translational Research (VICTR). -
June 8, 2017
VUMC lands renewal of Clinical and Translational Science Award
Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH). -
February 9, 2017
New grants bolster Trauma program’s research initiatives
Vanderbilt University Medical Center’s Division of Trauma, Emergency General Surgery and Surgical Critical Care was recently awarded two new research grants. -
December 8, 2016
Plasmin prevents muscle ‘hardening’ after injury: study
Vanderbilt researchers have made the surprising discovery that the protease plasmin, known for its clot-busting role in the blood, protects soft tissue from turning to bone after severe injuries and certain orthopaedic surgeries. -
November 17, 2016
Food study seeks to help employees make healthier choices
When dining in the Medical Center North breakroom or the Simply-to-Go counter at Courtyard Café, Vanderbilt University Medical Center employees can get a little help making informed food choices by picking a color: green, yellow or red. -
July 19, 2016
Harrell to step down as chair of Biostatistics
Frank Harrell Jr., Ph.D., professor of Biostatistics and founding chair of Vanderbilt’s Department of Biostatistics in 2003, will step down as chair after the completion of a national search for his successor. -
July 5, 2016
Vanderbilt establishes innovation center to boost demographic representation in clinical trial enrollment
Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this.